Expanded Access to Psychedelic Treatments: Comparing American and Canadian Policies
A policy analysis comparing Canada’s Special Access Program and the U.S. FDA’s Expanded Access Program for psychedelic-assisted therapy.
Drug Policy8
Check out the latest posts
Tacoma Resolution 41609 - Deprioritization of Local Enforcement Against Entheogens
Tacoma’s Resolution 41609 deprioritizes law enforcement against entheogens, supporting decriminalization and mental health research.
Rhode Island H5186 - Uniform Controlled Substances Act Amendment
Rhode Island’s proposed bill H5186 would allow personal cultivation of psilocybin and create a pathway for regulated medical use pending federal changes.
New Hampshire HB528 - Legalization of Psilocybin for Adults 21+
HB528 proposes legalizing psilocybin for adults 21+ in New Hampshire, removing criminal penalties while maintaining age restrictions.
Psilocybin Mushroom Stewardship: A Qualitative Inquiry into Practices and Priorities of “Underground” Psilocybin Mushroom Practitioners
A study on underground psilocybin practitioners reveals key practices, ethical concerns, and policy priorities for safe and effective facilitation.
Personal and Social Connection to Psychedelics is Associated with Lower Drug Use Stigma Among Psychiatrists in the United States
Study finds psychiatrists with personal or social experience with psychedelics show lower stigma toward drug use and users, suggesting educational benefits.